Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Society for Biomolecular Sciences and Association for Laboratory Automation to Combine Forces

By LabMedica International staff writers
Posted on 18 May 2010
For most of the past two years, the leaders of the Society for Biomolecular Sciences (SBS; Danbury, CT, USA) and the Association for Laboratory Automation (ALA; Geneva, IL, USA) have been organizing a merger to unite their scientific societies as one inclusive organization--the Society for Laboratory Automation and Screening (SLAS). More...


As of May 5, 2010, both memberships officially authorized the merger with more than 95% of the votes cast in favor. SBS and ALA will now unite as individual sections of SLAS. Each section will continue to pursue their current mission while collectively addressing the SLAS mission, which is to provide forums for education and information exchange to encourage the study of and improve the science and practice of laboratory automation and screening.

Under the SLAS umbrella, the SBS and ALA sections each will preserve SBS's and ALA's former identities and specialized educational pursuits. Moreover, both will benefit from the expanded scope, international influence, and enhanced program and service offerings that the unified organization will provide.

Inaugural SLAS president Michelle Palmer, Ph.D., Broad Institute of the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Harvard University (Cambridge, MA, USA) said, "SLAS will become the premier international community dedicated to advancing scientific research and discovery through laboratory automation and screening technology. We are extremely excited and gratified that the members of both SBS and ALA supported the merger so enthusiastically. We will celebrate today--and then get to work tomorrow. We are now faced with one of the most important steps in the evolution of our organizations. Our current objective is to bring the two organizations together over a transition period of about a year. And, of course, we will be looking for members to join us and contribute as volunteers on many of the new SLAS committees and working groups.”

Dr. Palmer in addition said, "The transition phase will take place throughout 2011, with SLAS supporting two annual conferences, one representing the original SBS section and another representing the original ALA section. Planned symposia, journals, and virtual services will continue. During this transition period, the new SLAS Board of Directors, together with the leadership of the SBS and ALA sections, will be working to develop and unveil a longer range strategy and educational vision for all activities under the SLAS umbrella.”

According to SLAS chief executive officer Greg Dummer, there is much on the horizon in the near term. "We will laser-in on the fundamentals of organizational transition throughout the next year to ensure the members of both organizations feel welcome in their new society, and continue to receive valued member benefits and services,” said Mr. Dummer. "Our objective right now is to be ready for business as a united new entity sometime later this year. With the traditional SBS and ALA conferences and exhibitions set for the first quarter of 2011, we have to maintain a high level of focus and determination; and we must look to appropriately blend some aspects of SLAS into each of these events.”

Mr. Dummer recapped that the transition process will follow through as planned and presented on the merger Web site, which includes information regarding ongoing services, office logistics, and personnel decisions. Mr. Dummer also reported that both scientific journals--Journal for Biomolecular Screening (JBS) and Journal of the Association for Laboratory Automation (JALA)--would continue their publishing schedules.

Mr. Dummer remarked that later in 2010, members will notice two new enhancements as a result of the merger: a unique, cutting-edge provision for membership-by-contribution, and a robust internship program to help develop emerging scientific talent in the field of laboratory automation and screening.

The Society for Laboratory Automation and Screening mission is to be the preeminent global organization providing forums for education and information exchange to encourage the study of, and improve the science and practice of, laboratory automation and screening.

Related Links:
Society for Biomolecular Sciences
Association for Laboratory Automation
Society for Laboratory Automation and Screening


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Blood Glucose Test Strip
AutoSense Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.